Skip to content

MLTX — Moonlake Immunotherapeutics Class A Ord Institutional Holders · Q3 2026

Who owns Moonlake Immunotherapeutics Class A Ord (MLTX)? 4 institutions reported holding $2.62M in SEC 13F filings for Q3 2026 (period ended 2026-09-30). Largest holders: Congress Asset Management Co ($2.6M), Farther Finance Advisors, LLC ($2,235), GAMMA Investing LLC ($164).

RankInstitutionValueSharesChange
1CONGRESS ASSET MANAGEMENT CO$2.6M223,883Added
2Farther Finance Advisors, LLC$2,235191Trimmed
3GAMMA Investing LLC$16414Hold
4Wealth Enhancement Trust Services, Inc.$00Exited

Source: SEC Form 13F filings · as of 2026-09-30